EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Gut microbiome and metabolome signatures in liver cirrhosis-related complications

Satya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, Sang Yoon Lee, Seol Hee Song, Jeoung Su Kim, Jeong Ha Park, Min Ju Kim, Dong-Hoon Yang, Hyunjoon Park, Sung-Min Won, Jin-Ju Jeong und 8 weitere

Clinical and Molecular Hepatology · 01.10.2024 · 30 (4) · 845-862

DOI: 10.3350/cmh.2024.0349 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, erschienen am 01.10.2024. Verfasst von Satya Priya Sharma und 19 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Korea. Hauptthemen laut MEDLINE: Liver Cirrhosis, Gastrointestinal Microbiome, Feces, Metabolome. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Hallym University, National Research Foundation of Korea, Ministry of Education, Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Shifts in the gut microbiota and metabolites are interrelated with liver cirrhosis progression and complications. However, causal relationships have not been evaluated comprehensively. Here, we identified complication-dependent gut microbiota and metabolic signatures in patients with liver cirrhosis.

Methods

Microbiome taxonomic profiling was performed on 194 stool samples (52 controls and 142 cirrhosis patients) via V3-V4 16S rRNA sequencing. Next, 51 samples (17 controls and 34 cirrhosis patients) were selected for fecal metabolite profiling via gas chromatography mass spectrometry and liquid chromatography coupled to time-of-flight mass spectrometry. Correlation analyses were performed targeting the gut-microbiota, metabolites, clinical parameters, and presence of complications (varices, ascites, peritonitis, encephalopathy, hepatorenal syndrome, hepatocellular carcinoma, and deceased).

Results

Veillonella bacteria, Ruminococcus gnavus, and Streptococcus pneumoniae are cirrhosis-related microbiotas compared with control group. Bacteroides ovatus, Clostridium symbiosum, Emergencia timonensis, Fusobacterium varium, and Hungatella_uc were associated with complications in the cirrhosis group. The areas under the receiver operating characteristic curve (AUROCs) for the diagnosis of cirrhosis, encephalopathy, hepatorenal syndrome, and deceased were 0.863, 0.733, 0.71, and 0.69, respectively. The AUROCs of mixed microbial species for the diagnosis of cirrhosis and complication were 0.808 and 0.847, respectively. According to the metabolic profile, 5 increased fecal metabolites in patients with cirrhosis were biomarkers (AUROC >0.880) for the diagnosis of cirrhosis and complications. Clinical markers were significantly correlated with the gut microbiota and metabolites.

Conclusions

Cirrhosis-dependent gut microbiota and metabolites present unique signatures that can be used as noninvasive biomarkers for the diagnosis of cirrhosis and its complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver CirrhosisGastrointestinal MicrobiomeFecesMetabolomeRNA, Ribosomal, 16SHumansMaleFemaleMiddle AgedAgedCase-Control StudiesROC CurveAdult

Stichwörter der Autor:innen

BiomarkerCirrhosisComplicationMetaboliteMicrobiota

Substanzen

RNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Institute for Liver and Digestive Diseases, Hallym University, Chuncheon, Korea.
  • Department of Nursing Daewon University College Jecheon, Korea.
  • Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

Förderung

  • Hallym University
  • National Research Foundation of Korea
  • Ministry of Education, Science and Technology
  • Korea Institute for Advancement of Technology

Zitieren

APA

Sharma, S. P., Gupta, H., Kwon, G. H., Lee, S. Y., Song, S. H., Kim, J. S., Park, J. H., Kim, M. J., Yang, D. H., Park, H., Won, S. M., Jeong, J. J., Oh, K. K., Eom, J. A., Lee, K. J., Yoon, S. J., Ham, Y. L., Baik, G. H., Kim, D. J., & Suk, K. T. (2024). Gut microbiome and metabolome signatures in liver cirrhosis-related complications. Clinical and Molecular Hepatology, 30(4), 845-862. https://doi.org/10.3350/cmh.2024.0349

Vancouver

Sharma SP, Gupta H, Kwon GH, Lee SY, Song SH, Kim JS, et al. Gut microbiome and metabolome signatures in liver cirrhosis-related complications. Clinical and Molecular Hepatology. 2024;30(4):845-862. doi:10.3350/cmh.2024.0349

BibTeX
@article{Sharma2024,
  author = {Sharma, Satya Priya and Gupta, Haripriya and Kwon, Goo-Hyun and Lee, Sang Yoon and Song, Seol Hee and Kim, Jeoung Su and Park, Jeong Ha and Kim, Min Ju and Yang, Dong-Hoon and Park, Hyunjoon and Won, Sung-Min and Jeong, Jin-Ju and Oh, Ki-Kwang and Eom, Jung A and Lee, Kyeong Jin and Yoon, Sang Jun and Ham, Young Lim and Baik, Gwang Ho and Kim, Dong Joon and Suk, Ki Tae},
  title = {Gut microbiome and metabolome signatures in liver cirrhosis-related complications},
  journal = {Clinical and Molecular Hepatology},
  year = {2024},
  volume = {30},
  number = {4},
  pages = {845--862},
  doi = {10.3350/cmh.2024.0349}
}
Kostenlos starten →